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Abstract Objective To investigate T cell activation following facial nerve axotomization and latent
neuroimmunologic mechanisms in traumatic facial paralysis. Methods A murine model of facial nerve
transaction was used. Lymphocytes from cervical and mesenteric lymph nodes in BABL/c mice at
specific times were collected and expression rates of CD69 on T cells were assessed by flow
cytometry. Results Infiltrating T cells were detected around the facial neurons in the facial nerve
nucleus in mice whose facial nerve was transected. Immunofluorescent staining showed recruitment of
activated T cells. Three days post-facial nerve transection, the expression rate of CD69 on T cells from
cervical draining lymphoid nodes(CDLNs) was significantly different from that on T cells from
mesenteric lymph nodes(MLNs) (P＝0.0457), whereas the latter was similar to that in animals
undergoing sham surgeries and that in blank control animals(p= 0.2817 and 0.2724, respectively). Two
weeks post-nerve transection, the T cell CD69 expression rate from CDLNs remained at a higher level
and than that in the sham-operation animals(p= 0.0007). At two weeks, CD69 expression rate on T
cells from MLNs was also up-regulated and different compared with the sham-operation animals and
with itself at three days postoperation(p= 0.0082 and 0.0133, respectively ). Conclusion T cells appear
to be activated and up-regulated in CDLNs following facial nerve transection. There is even evidence of
T cell activation in MLNs at 2 weeks post-nerve transection. This suggestes an alteration of immune
response from local to general immunity in the acute stage of facial nerve trauma, which may help
coordinating and controlling the scales and orientation of the neuroimmune response during the
pathogenesis and progression of facial nerve trauma.
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1 Introduction
T cell activation plays an important role in
triggering immune response in many diseases,
including nerve injury[1, 2]. Interest in immune
activation in facial nerve injury is increasing
because studies have shown that irreversible
axonal damage occurs earlier than previously
thought[3]. The classic viewpoint of facial nerve
injury pathology focuses on demyelinating lesions
characterized by the presence of T cells, B cells
and phagocytic macrophages[4]. Disease activity is
probably initiated by systemic activation of
myelin-reactive T cells, followed by activated T
cell migration into the central nerve system
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(CNS), including facial nucleus, and the sequential
recruitment of additional inflammatory cells to
facial motoneurons [5]. Cells primarily accumulate
in the perivascular space and subsequently
migrate into the CNS parenchyma. The
recruitment and migration of leukocytes into the
CNS are orchestrated by chemokines. And
activated T cells that express specific
combi-nations of adhesion molecules and
chemokine receptors are preferentially attracted
to CNS by chemokines produced within the
target tissue. Hence, in patients with facial nerve
injury, the expression of adhesion molecules and
chemoki-nes on the surface of activated T cells
governs the recruitment of immune cells to the
CNS [6, 7]. Moreover the expression of other
activation and differentiation molecules reflects
the function of recruited T cells. However, the
status of T cells and definitive molecular and
cellular immuno-pathological mechanisms in
facial nerve injury are unknown.
CD69 is the earliest cell surface marker ex⁃
pressed in activated immune cells. Generally
speaking, in static state (without being stimulat⁃
ed), the immune cell does not express CD69, al⁃
though it can be rapidly spurred to expressing by
stimulating signals[8]. Therefore, CD69 is the ideal
index to appraise immune cell’s state of
fun-ction [9-12]. Its stimulation leads to IL-2 pro⁃
duction and increases CD25 expression, finally
causing T cell proliferation. The present study
was consequently undertaken to detect the pres⁃
ence of activated T cells in a mouse model with
facial nerve transection. To this point, T lympho⁃
cytes collected from cervical draining lymph
nodes (CDLNs) and the mesenteric lymph
nodes(MLNs) were used to represent local and
“remote”(systemic) immune responses respec⁃
tively in the current study. Early activation antigen
CD69 on T cells was examined by flow cytometry
so as to provide preliminary reference data on la⁃
tent neuroimmunologic mechanisms of traumatic
facial paralysis.
2 Materials and methods
2.1 Animals and surgical procedures
All BABL/c mice used in the present study
were specific pathogen-free(SPF) animals. Sev⁃
en-week-old male wild-type mice were ob⁃
tained from Institute of Laboratory Animal Sci⁃
ence, Chinese Academy of Medical Science (Bei⁃
jing, China). All mice were provided autoclaved
pellets and water ad libitum. Mice were permit⁃
ted 1 week to acclimate to their environment be⁃
fore manipulation and used at 8 weeks of age in
all experiments. All mice were housed under a
12-h light/dark cycle in microisolater cages con⁃
tained within a laminar flow system to maintain a
pathogen-free environment. All surgical proce⁃
dures were completed in accordance with China
Academic of Medical Science guidelines on the
care and use of laboratory animals for research
purposes. Mice were anesthetized with 10%
Chloral Hydrate for all surgical procedures. Using
aseptic techniques, the right facial nerve of ani⁃
mals in the facial nerve transection group was ex⁃
posed at its exit from the stylomastoid foramen
and completely transected. The proximal and the
distal nerve stump were reset without suture. Be⁃
havioral observations were used to assess recon⁃
nection of the facial nerve(i.e., if the animal recov⁃
ered from unilateral facial paralysis). For animals
in the sham operation group, the right facial
nerve was exposed, but not transected. For both
groups, the left side was untreated and served as
an internal control in comparison to the right side.
A separate group of untreated BABL/c mice were
included as blank control. Six animals from each
group were examined and tested at 3 (DPO3) and
14 (DPO14) days post operation, respectively.
2.2 Light microscopic immunohistochemistry stain⁃
ing with CD3
2.2.1 Brain stem slice preparation
After the animals were killed with overdose
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10% Chloral Hydrate, they were first perfused in⁃
tracardially(30 ml/min) with 200 ml of phosphate
buffer solution (PBS) (10 mM Na2HPO4 , 0.84%
NaCl, pH 7.4), followed by 200 ml of 4% for⁃
ma-ldehyde (FA) in PBS (4% FA/PBS), and the
brain stem was removed and post-fixed by 2 hr
immersion in 1% FA/PBS at 4° C on a rotator (8
rpm). The tissue was cryoprotected by an over⁃
night rotating immersion in sucrose (30% su⁃
crose, 10 mM Na2HPO4, pH 7.4, 4°C), frozen on
dry ice, and then cut in a cryostat at the level of
the facial motor nucleus. Sections(30 μm) were
collected on warm, 0.5% gelatin-dipped slides.
2.2.2 Immunohistochemistry staining with CD3
Tissue sections were incubated with the prima⁃
ry anti-mouse CD3 antibodies(PharMingen) over⁃
night, then with biotinylated goat anti-rat second⁃
ary antibody and avidin-biotin peroxidase com⁃
plex (ABC, Vector), completed with visualization
with diaminobenzidine/H2O2(DAB, Sigma). Sec⁃
tions were washed in PBS following each incuba⁃
tion step.
2.2.3 Light microscope examination of facial nu⁃
cleus
Examination of the facial nerve nucleus was
completed at the central lab of Peking Union Med⁃
ical College Hospital with a Nikon microscope
(Eclipse 80i). Sections of facial nucleus were ex⁃
amined for distribution and recruitment of T cells
with positive CD3 staining, identified in Buffy col⁃
or under the microscope.
2.3 Double-color immunofluorescent staining with
antibodies and flow cytometry
Anti-CD3 mAb (monoclonal antibodies) -FITC,
anti-CD69 mAb-PE and isotype-specific control
antibodies were obtained from eBioscience (San
Diego, CA) Lymphocytes harvesting and fluores⁃
cence antibody staining have been described pre⁃
viously in detail [11, 12]. In brief, the lymphocytes sep⁃
arated from CDLNs and MLNs at DPO3 and
DPO14 were suspended in RPMI1640 with 10%
fetal bovine serum, with the concentration adjust⁃
ed to 109 cell/L. After counting survival percent⁃
age with trypan blue, the suspension was
washed twice with PBS and condensed to 50 μL.
The suspension was incubated for 30 min in the
dark at room temperature with the appropriate di⁃
lution of anti-CD3 mAb-FITC and anti-CD69
mAb-PE, washed twice with cold PBS, and final⁃
ly fixed with 4% paraformaldehyde to ready for
testing. Drops containing targeting cells from
CDLNs were examined and photographed under
fluorescence microscope with double-color im⁃
munofluorescent staining. A EPICS XL flow cy⁃
tometer (Beckman-Coulter) was used for flow cy⁃
tometry analysis. Three samples were collected
and tested on each set test day. Data are present⁃
ed as mean±s, and differences between groups
were compared using t-test. P value <0.05 is set
as statistically significant.
3 Results
None of the animals in the present study
showed signs of recovering from unilateral facial
paralysis after facial nerve transection.
3.1 CD3 in facial nucleus
CD3 is one of the specific cell surface markers
on T cells. Its expression on T cells in the facial
nucleus in this study is depicted in Figure 1 as
positive staining under the microscope.
3.2 Immunofluorescent staining of T cells from
CDLNs in mice with facial nerve transection
Expression of T cell surface marker CD69 was
visible under oil immersion lens following
CD3-FITC, CD69-PE double-color immunofluo⁃
rescent staining, indicating T cell activation (Fig
2).
3.3 Expression of CD69 on T cells three days after
operation.
CD69 antigen was minimally or not expressed
on CD3+ T cells from lymph nodes in blank con⁃
trol group mice in the state of quiescence. Three
days after the operation, CD69 expression was
seen on CD3 + T cells from CDLNs in mice that
R
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had undergone facial nerve transection or
sham-operation (Fig. 3A and B), indicating T cell
activation. This was significantly different com⁃
pared with T cells from MLNs (P=0.0457 and
0.0226, respectively). CD69 expression was posi⁃
tive on 0.81 ± 0.21% of T cells from CDLNs in
mice with facial nerve transection, compared to
0.52 ± 0.16% in those in the sham-operation
group (P=0.2759). CD69 expression rates in T
cells from MLNs were similar in the nerve tran⁃
section and sham-operation groups (P=0.4700)
(Fig. 3C and 3D).
3.4 Expression of CD69 on T cells 14 days after op⁃
eration.
Two weeks after facial nerve transection,
CD69 expression on T cells from CDLNs re⁃
mained positive (0.62±0.10) % and not significant⁃
ly different from 3 days after operation (P=
0.2294), indicating continuous T cell activation.
However, CD69 expression on CDLN T cells in
sham-operation mice had dropped to normal lev⁃
els at 0.14 ± 0.01% (Fig. 3F), lower than that at
DPO3 (P=0.0212). A significant difference in ex⁃
pression of CD69 on T cells from CDLNs was
seen between mice with transected facial nerve
and those in the sham-operation group(P=
0.0007). At the same time, CD69 expression on T
cells from MLNs increased in mice with facial
nerve transection to 0.49±0.05% (Fig. 3G), higher
than sham-operation mice and than at DPO3(P=
0.0082 and P=0.0133, respectively) (Fig. 3H).
4 Dｉｓｃｕｓｓｉｏｎ
At present, Neuritis and demyelization are gen⁃
erally acknowledged as common pathophysiologi⁃
cal foundation of peripheral facial paralysis (Bell’s
palsy, traumatic, infectious and others) by schol⁃
ars home and abroad[4,13 ]. Cellular immune re⁃
sponse and humoral immune response play a key
role in the outbreak and development of peripher⁃
Figure 1 CD3 expression in facial nucleus. A: Lack of CD3 expression in facial nucleus on the left (non-operative)
side with a clean background. DAB×400. B: CD3 expression in facial nucleus on the right (operative) side 3 days
post operation in the same mouse. Positive CD3 staining is visible against a clean background, representing T cell
infiltration around facial motoneurons. DAB×400）
Figure 2 Immunofluorescent staining of T cells from
CDLNs in a mouse 14 days after facial nerve transec⁃
tion. Green-CD3-FITC staining; red-CD69-PEstain⁃
ing. Double-color CD3-FITC and CD69-PE immunoflu⁃
orescent staining is seen in orange color (CD3+CD69+
cells), indicating activated T cells (×1000).
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al facial paralysis[14,15]. However, precise cellular
and molecular immune mechanisms of peripheral
facial paralysis have not been discovered so far,
leading to a weak foundation of theories to the
contemporary treatment. With currently available
treatments (conservative medical treatments, sur⁃
geries, and complimentary treatments including
traditional Chinese herbal medicines and acupunc⁃
ture and moxibustion), a significant number of pa⁃
tients are left with such sequelae as facial paraly⁃
sis and permanent facial deformity, causing great
agony and psychological burden to them [16]. It can
be inferred from our previous research that the
representative immune cell activation and recruit⁃
ment of T cell and monocyte/macrophage may be
the cellular immunity foundations of peripheral fa⁃
cial nerve demyelization and facial motoneuron
death[17, 18]. The pathophysiological meanings of T
cell activation and CD69 expression in a mouse
model of traumatic peripheral facial paralysis
were probed here with fluorescence-activated
cell sorting.
T cell activation is a result of complicated ac⁃
tion between multiple ligand-receptors, which
are offered by T cells and antigen-presenting
cells (APC) including the formation of immunologi⁃
cal synapse(IS)[19,20]. The interactive integration trig⁃
gers biochemistry events in T cells that lead to
Figure 3 Expression of CD69 on T cells at DPO3 (A-D) and, DPO14(E-H). A, B, E and F: T cells from CDLNs in
the facial nerve transection (A and E) and sham-operation (B and F) groups, respectively. C, D, G and H: T cells
from MLNs in the facial nerve transection (C and G) and sham-operation (D and H) groups, respectively.
Group
Facial nerve transection
Sham-operation
P2
DPO3
CDLN
0.81 ± 0.21
0.52 ± 0.12
0.2759
MLN
0.18 ± 0.00
0.17 ± 0.08
0.4700
P1
0.0457
0.0226
DPO14
CDLN
0.62 ± 0.10
0.14 ± 0.01
0.0007**
MLN
0.49 ± 0.05
0.10 ± 0.00
0.0082**
P1
0.1397
0.0386
Tab 1 Expression of CD69 on T cells ( x± s，%)
NOTE: (1) P1, CDLN vs MLN; P2, Facial nerve transected group vs Sham-operation group
（2）*P <0.05, (**)P <0.01
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cellular immune response. Such effects as accel⁃
eration or inhibition on activation, proliferation, dif⁃
ferentiation and effector action are carried out
through cytokines secretion and cell-cell contact.
T cell activation plays a key role either in normal
or in pathological immune response. The degree
and direction of immune response are deter⁃
mined by the upshot of T cell activation.
Three days post the operation, CD69 expres⁃
sion ascended in CD3+ T cells from CDLN in ani⁃
mals with facial nerves transection and sham-op⁃
eration(Fig. 3 A and B) compared to T cells from
MLNs, which reflected the systemic immune sta⁃
tus, as in a“far site” local immune response.
This suggest that the organism starts or increas⁃
es local cellular immune response in response to
a combined acute stage effect by trauma and
nerve injury with activated T cells, although the
systemic immune response is yet to start. The
similarly high levels of CD69 expression in CD3+
T cells from the CDLN two weeks after facial
nerve transection suggests continuous T cell acti⁃
vation. At this time, CD69 expression on CDLN T
cells in animals with sham-operation had
dropped to a normal level, similar to that at 3
days post operation, suggesting that the organ⁃
ism had recovered from unsophisticated trauma⁃
tism (no-nerve-transected) with the normal level
immunity response. Neural traumatism effect in⁃
cludes antigen exposure, continuous repair and
generation based on low-level autoimmune re⁃
sponse. A moderate upregulation of immune reg⁃
ulation network is needed to exert the function of
immune elimination and immune surveillance.
The status with appropriate T cell activation is a
primary step to triggering the adjustment and con⁃
trol of the network.
The results of light microscopic immunohisto⁃
chemistry and immunofluorescent staining indi⁃
cate distribution and recruitment of T cells in the
facial nucleus (Fig 1-2), confirming that, mediat⁃
ed by T cell’s antigen receptor, CD4+ T cells are
activated by distinguishing peptides including au⁃
toantigens such as myelin basic protein (MBP)
and proteolipid proteins (PLP), presented by anti⁃
gen presenting cells (APC) such as stelliform glial
cells, glial cell (GC) and Schwann cells. Then, acti⁃
vated CD4+ T cells overshoot blood brain barrier
(BBB) and infiltrate facial nucleus [21]. Activated T
cells, small GCs and stelliform GCs produce vari⁃
ous kinds of chemokine, cytokines and adhesive
molecules which recruit more T cells and mono⁃
cytes / macrophages around the peripheral injury
area and facial nucleus. Two effects are brought
about: first, clearing and phagocytization of
necr-otic metamorphic motorneurons, myelin
sheath and axon, etc; second, secondary allergy
and experimental autoimmune encephalomyeli⁃
tis(EAE) induced by conglomeration of inflamma⁃
tory cells dominated by T cells and macrophages
[22, 23]. There is a dynamic course for immune regu⁃
lation in the immune system.
CD69 expression upregulation in T cells from
MLNs is probably through the mechanism of sys⁃
temic immune regulation networks started by lo⁃
cal immune response. Two weeks after nerve in⁃
jury, the upregulation of CD69 expression in T
cells of lymph nodes is simply the result of the
surveillance mechanisms of the immune regula⁃
tion network, which is started by the key process
immune response with appropriate T cell activa⁃
tion. Abnormal T cell activation, too high or too
low, means nerve pathological emergence for the
organism(autoimmunity / immune deficiency) [24].
The restorative effect in early stage of facial
nerve injury (in two weeks) determines the result
of final nerve repair. The change of micro-envi⁃
ronmental in damaged nerve cells and axons, es⁃
pecially the expressions of various kinds of im⁃
mune cells and molecules together with the dy⁃
namic equilibrium of their regulating networks, is
the key incidents of nerve repair and regenera⁃
tion. They impenetrate from the start to the end
of rehabilitation and regeneration of nerve’s inju⁃
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ry. The conception of‘immune microenviron⁃
ment for repair and regeneration of facial nerve’,
as we have previously introduced [17,18, 25], mainly
concerns with the change of expression and regu⁃
lation network with various immune cells and im⁃
mune molecules in the process of facial nerve
renovation. It is a dynamic equilibrium for its main⁃
tenance of the normal immune microenviron⁃
ment. It is the activated T cells that target to re⁃
cruiting such immune activated cells as mono⁃
cytes/macrophages, such cytokines as neuro⁃
trophic factors, which regulate Schwann cells pro⁃
liferation and continuous axon regeneration [26].
Studies have showed that specific T cell sub⁃
groups have a relationship with the survival of fa⁃
cial motorneurons[18, 27]. Many questions remain:
what are the roles of dialogue mechanisms of T
cell-axon / neuron-Schwann cells / glial cell?
Which factors, and through which concrete signal
pathways, play a key role for T cells and mono⁃
cytes/macrophages system activation and recruit⁃
ment? What are the roles of real molecular mech⁃
anisms of the action by specific T cells on facial
motor neurons survival? We believe that they will
be well explained with the progress of systemat⁃
ic studies on immune microenvironment for re⁃
pair and regeneration of facial nerve.
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